# US 2010/0168422 A1 · Methods and intermediates useful in the synthesis of hexahydrofuro [2,3-b]furan-3-ol

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168422 A1
- Document ID: US20100168422A1
- Status: Published application
- Kind: A1
- Application number: 12/345,838
- Filed: 2008-12-30
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Inventors: Weiping Chen
- Web page: https://patentgrep.com/patent/US20100168422A1

## CPC

- C07D 295/088: to an acyclic saturated chain
- C07C 239/12: having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
- C07D 307/33: in position 2, the oxygen atom being in its keto or unsubstituted enol form
- C07D 493/04: Ortho-condensed systems
- C07F 9/4006: {Esters of acyclic acids which can have further substituents on alkyl}
- C07F 9/6561: containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

Provided herein are compounds and methods useful for preparing hexahydrofuro[2,3-b]furan-3-ol. Hexahydrofuro[2,3-b]furan-3-ol can be efficiently synthesized in four steps from readily available starting materials.

## Claims

### Claim 1

A process for preparing a compound of Formula 7:
comprising:
(a) combining a reducing agent and a compound of Formula 5:
or a salt thereof, wherein:
X is S or O;
Y is O, —N(R3)—, or a bond;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
each of R1 R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl; or
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
to give a compound of Formula 6:
or a salt thereof, wherein: each of Y, R1 and R2 is as defined above; and combining said compound of Formula 6 with an acid to give said compound of Formula 7.

### Claim 2 (depends on 1)

The process of claim 1, wherein said reducing agent is MBH4, MHB(R3)3, MH2B(R4)2, MH3BR4, MHB(OR4)3, MH2B(OR4)2, MH3BOR4, MAlH4, MHAl(OR4)3, MH2Al(OR4)2, MH3Al(OR4), HB(R4)2, H2BR4, BH3, H2Al(R4)2, H2AlR4, or H3Al;
M is Li, Na, K, R34N, ½Zn or ½Ca; and
R4 is alkyl or aralkyl.

### Claim 3 (depends on 1)

The process of claim 1, wherein said acid is hydrochloric acid, hydrobromic acid sulfuric acid, phosphoric acid, nitric acid, metal hydrogen sulfate, metal dihydrogen phosphorate, trifluoroacetic acid, trichloroacetic acid, citric acid, oxalic acid, tartaric acid, oxalic acid, formic, methanesulfonic acid, trifluoromethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, 10-camphorsulfonic acid, 1,5-napthalene disulfonic acid, or 1,2-ethane disulfonic acid.

### Claim 4 (depends on 1)

The process of claim 1, wherein said compound of Formula 7 is

### Claim 5 (depends on 1)

The process of claim 1, wherein R is alkyl.

### Claim 6 (depends on 1)

The process of claim 1, wherein Y is a bond; and each of R1 and R2 independently for each occurrence is alkyl, cycloalkyl, aryl, or —[C(R10)2]m—R11, wherein independently for each occurrence R10 is hydrogen or alkyl, R11 is alkoxy; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 5-8 membered optionally substituted heterocyclic ring.

### Claim 7 (depends on 1)

The process of claim 1, wherein Y is a bond; R is alkyl; and each of R1 and R2 independently for each occurrence is alkyl, cycloalkyl, aryl, or —[C(R10)2]m—R11, wherein independently for each occurrence R10 is hydrogen or alkyl, R11 is alkoxy; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 5-8 membered optionally substituted heterocyclic ring.

### Claim 8 (depends on 1)

The process of claim 1, wherein Y is a bond; R is methyl, ethyl, n-propyl, or i-propyl; X is O; and R1 and R2 taken together with the nitrogen to which they are bonded form a heterocyclic ring selected from piperidine, pyrrolidine, or morpholine.

### Claim 9 (depends on 1)

The process of claim 1, further comprising:
combining a compound of Formula 3:
or a salt thereof, wherein:
X is S or O;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
a coupling agent; and
a compound of Formula 4:
or a salt thereof, wherein
Y is O, —N(R3)—, or a bond;
each of R1 R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
to give said compound of Formula 5.

### Claim 10 (depends on 9)

The process of claim 9, wherein said coupling agent is dicyclohexylcarbodiimide (DCC), diisopropylcarbodiimide (DIC), N,N′-carbonyldiimidazole (CDI), 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT), 1-ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride (EDCL). 2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU). 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HABTU), 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium hexafluorophosphate (HCTU), benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBOP). bromo-tris-pyrrolidino-phosphonium hexafluorophosphate (PyBrOP). O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate (TATU), 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU). N,N,N′,N′-tetramethyl-O-(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)uronium tetrafluoroborate(TBTU), O-(N-succinimidyl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TSTU), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM), 2-chloro-4,6-dimethoxy-1,3,5-triazine/N-methylmorpholine (CDMT/NMM), oxalyl chloride, SOCl2, SO2Cl2, POCl3, PCl3, PCl5, PBr3, PBr5POBr3, pivaloyl chloride, or pivaloyl anhydride.

### Claim 11 (depends on 9)

The process of claim 9, wherein said coupling agent is CDI, DMTMM, or EDCL and said compound of Formula 4 is morpholine.

### Claim 12 (depends on 10)

The process of claim 10, wherein R is methyl, ethyl, n-propyl, or i-propyl; X is O; and said compound of Formula 4 is morpholine.

### Claim 13 (depends on 9)

The process of claim 9, further comprising:
combining a compound of Formula 1:
and a compound of Formula 2:
RXH 2
or a salt thereof, wherein:
X is S or O;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR2, —CO2R2, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
to give said compound of Formula 4.

### Claim 14 (depends on 13)

The process of claim 13, wherein said compound of Formula I is
and said compound of Formula 2 is methanol, ethanol, n-propanol, or i-propanol.

### Claim 15

A process for preparing a compound of Formula 7a:
comprising:
(a) combining methanol, ethanol, n-propanol, or i-propanol, and a compound of Formula 1a:
to give a compound of Formula 3a:
(b) combining said compound of Formula 3a, morpholine, and EDCL to give a compound of Formula 5a:
(c) combining said compound of Formula 5a with LiAlH4 to give a compound of Formula 6a:
or a salt thereof, and
(d) combining said compound of Formula 6a or a conjugate acid thereof, and NaHSO4 to give said compound of Formula 7a.

### Claim 16

A compound of Formula 5:
or a salt thereof, wherein:
X is S or O;
Y is O, —N(R3)—, or a bond;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
each of R1 R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R2)(R3), —N(R2)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8.

### Claim 17 (depends on 16)

The compound of claim 16, wherein Y is a bond; R is alkyl; and R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring.

### Claim 18 (depends on 16)

The compound of claim 16, wherein said compound has the absolute stereochemistry shown below:

### Claim 19 (depends on 16)

The compound of claim 16, wherein said compound of Formula 5 is prepared by a process comprising:
(a) combining a compound of Formula 1a:
and a compound of Formula 2:
RXH 2
or a salt thereof, wherein:
X is S or O;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
to give a compound of Formula 3a:
or a salt thereof, wherein: R is as defined above;
(b) combining said compound of Formula 3a with a coupling agent; and
a compound of Formula 4:
or a salt thereof, wherein
Y is O, —N(R3)—, or a bond;
each of R1, R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
to give said compound of Formula 5.

### Claim 20

A compound of Formula 3a:
or a salt thereof, wherein:
X is S or O;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
provided that when R is 1-butyl, then X is not O;
further provided that when R is menthyl, then X is not O
further provided that when R is benzyl, then X is not O.

### Claim 21 (depends on 20)

The compound of claim 20, wherein R is alkyl and X is O.

### Claim 22 (depends on 20)

The compound of claim 20, wherein said compound has the absolute stereochemistry shown below:

### Claim 23 (depends on 20)

The compound of claim 20, wherein said compound of Formula 3a is prepared by a process comprising:
(a) combining a compound of Formula 1a:
and a compound of Formula 2:
RXH 2
or a salt thereof, wherein:
X is S or O;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, −OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
to give said compound of Formula 3a.

### Claim 24

A compound of Formula 6a:
or a salt thereof, wherein:
Y is O, —N(R3)—, or a bond;
each of R1, R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8.

### Claim 25 (depends on 24)

The compound of claim 24, wherein said compound has the absolute stereochemistry shown below:

### Claim 26 (depends on 24)

The compound of claim 24, wherein Y is a bond and R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring.

### Claim 27 (depends on 24)

The compound of claim 24, wherein said compound of Formula 6a is prepared by a process comprising:
(a) combining a compound of Formula 1a:
and a compound of Formula 2:
RXH 2
or a salt thereof, wherein:
X is S or O;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
to give a compound of Formula 3a:
or a salt thereof, wherein: R is as defined above;
(b) combining said compound of Formula 3a with a coupling agent; and
a compound of Formula 4:
or a salt thereof, wherein
Y is O, —N(R3)—, or a bond;
each of R1 R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
to give a compound of Formula 5a:
or a salt thereof, wherein each of R, R1, and R2, are as defined above; and
(c) combining said compound of Formula 5a with a reducing agent to give said compound of Formula 6a.

### Claim 28

A compound selected from the group consisting of:
or salts thereof.

### Claim 29

A process for preparing a compound of Formula 7:
comprising:
(a) combining an acid and a compound of Formula 3:
or a salt thereof, wherein:
Y is O, —N(R3)—, or a bond;
each of R1 R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8; to give said compound of Formula 7.

### Claim 30

A process for preparing a protease inhibitor comprising:
(a) combining a reducing agent and a compound of Formula 5a:
or a salt thereof, wherein:
X is S or O;
Y is O, —N(R3)—, or a bond;
R is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11;
each of R1 R2, and R3 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, or —[C(R10)2]m—R11; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring; or R1 and R3 taken together with the nitrogen to which they are bonded represent a 3-10 membered optionally substituted heterocyclic ring;
R10 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl;
R11 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, halide, nitrile, nitro, —OR12, —N(R12)COR13, —N(R12)C(O)OR13, —N(R12)SO2(R13), —CON(R12)(R13), —OC(O)N(R12)(R13), —OC(O)OR12, —CO2R12, —OC(O)R12, —C(O)N(OR12)(R13), or —SO2N(R12)(R13), —N(R12)S(O)2OR13;
each of R12 and R13 independently for each occurrence is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl; or R12 and R13 taken together represent a 5-8 membered optionally substituted heterocyclic ring; and
m is 0-8;
to give a compound of Formula 6a:
or a salt thereof, wherein: each of Y, R1 and R2 is as defined above;
(b) combining said compound of Formula 6a with an acid to give a compound of Formula 7a:
(c) combining-said compound of Formula 7a with a carbamate coupling agent to give an activated carbonate; and
(d) combining said activated carbonate with an amine containing protease inhibitor precursor.

### Claim 31 (depends on 30)

The process of claim 30, wherein said amine containing protease inhibitor precursor is:
(i) a compound of Formula 13:
or a salt thereof; and said protease inhibitor is a compound of Formula 13a:
or a salt thereof;
(ii) a compound of Formula 14:
or a salt thereof; and said protease inhibitor is a compound of Formula 14a:
or a salt thereof;
(iii) a compound of Formula 15:
or a salt thereof; and said protease inhibitor is a compound of Formula 15a:
or a salt thereof;
(iv) a compound of Formula 16:
or a salt thereof; and said protease inhibitor is a compound of Formula 16a:
or a salt thereof;
(v) a compound of Formula 17:
or a salt thereof; wherein Ar independently for each occurrence is aryl; and said protease inhibitor is a compound of Formula 17a:
or a salt thereof; wherein Ar independently for each occurrence is as defined above;
(vi) a compound of Formula 18:
or a salt thereof, wherein Ar is aryl; A is CH2, S, or O; and R′ independently for each occurrence is alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl; and said protease inhibitor is a compound of Formula 18a:
or a salt thereof; wherein each of Ar, A, and R′ are defined as above;
(vii) a compound of Formula 19:
or a salt thereof, wherein Ar′ independently for each occurrence is aryl optionally substituted with a water soluble oligomer and R″ is an alkyl or a water soluble oligomer, provided that at least one of Ar′ or R″ comprises a water soluble oligomer; and said protease inhibitor is a compound of Formula 19a:
or a salt thereof; wherein each of Ar′ and R″ are as defined above; or
(viii) a compound of Formula 20:
or a salt thereof, wherein Ar is aryl; each of R′″ independently for each occurrence is hydrogen, alkyl, heteroaryl, aralkyl, or heterocycloalkyl; and said protease inhibitor is a compound of Formula 20a:
or a salt thereof; wherein each of Ar and R′″ are as defined above.

### Claim 32 (depends on 30)

The process of claim 30, wherein said carbamate coupling agent is selected from the group consisting of phosgene, trichloromethyl chloroformate, bis(trichloromethyl) carbonate, bis(4-nitrophenyl) carbonate, bis(pentafluorophenyl) carbonate, N,N′-disuccinimidyl carbonate, 4-nitrophenyl chloroformate, 2,2′-dipyridyl carbonate, and N,N′-carbonyldiimidazole (CDI).

### Claim 33 (depends on 30)

The process of claim 30, wherein R is alkyl; X is O; and each of R1 and R2 independently for each occurrence is alkyl, cycloalkyl, aryl, or —[C(R10)2]m—R11, wherein independently for each occurrence R10 is hydrogen or alkyl, R11 is alkoxy; or R1 and R2 taken together with the nitrogen to which they are bonded represent a 5-8 membered optionally substituted heterocyclic ring.

### Claim 34 (depends on 30)

A protease inhibitor prepared by the process of claim 30.
